Stay updated on Clinical Trial: TTF+IO±CTLA-4 for Recurrent Glioblastoma

Sign up to get notified when there's something new on the Clinical Trial: TTF+IO±CTLA-4 for Recurrent Glioblastoma page.
Latest website image capture
Clouds background image

Latest updates to the Clinical Trial: TTF+IO±CTLA-4 for Recurrent Glioblastoma page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-04-30T13:37:16.000Z thumbnail image
  3. Check
    23 days ago
    Change Detected
    Summary
    The webpage has been updated to reflect a new phase II trial for recurrent glioblastoma, detailing the study's design, participant criteria, and treatment regimen, while removing outdated information about a previous phase I/II trial.
    Difference
    41%
    Check dated 2025-04-16T01:00:39.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-08T19:31:09.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T13:31:17.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-02-24T13:39:50.000Z thumbnail image
  7. Check
    87 days ago
    Change Detected
    Summary
    The page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    1%
    Check dated 2025-02-10T08:54:03.000Z thumbnail image

Stay in the know with updates to Clinical Trial: TTF+IO±CTLA-4 for Recurrent Glioblastoma

Enter your email address, and we'll notify you when there's something new on the Clinical Trial: TTF+IO±CTLA-4 for Recurrent Glioblastoma page.